Vivinex™

 
js_function_caller_helper
HOYA Vivinex™ Toric multiSert™ (XY1A-SP)
 

Vivinex™ Toric IOL offers clarity of vision and outstanding rotational stability. Delivered by multiSert™, providing unmatched control at your fingertips.

HOYA Vivinex™ Toric multisert™

Vivinex™ Toric multiSert™

Clarity and Control combined with outstanding rotational stability

 

Designed to provide outstanding optical quality, Vivinex™ offers clarity of vision for patients suffering from cataract. Product quality, dedication and attention to detail are deeply rooted in our Japanese heritage and with 2 million lenses inmplanted worldwide, surgeons‘ trust in Vivinex™ is proven.

Vivinex™ Toric offers the following benefits

  • Glistening-free hydrophobic acrylic IOL material 1,2
  • Proprietary aspheric optic design for improved image quality 3
  • Active oxygen processing treatment, a smooth surface and square optic edge to reduce PCO 2,4,5,6,7,8,9,10
  • Median rotation 1.1° [range: 0.0°–5.0°] 100% of lenses (n=103) had ≤5° of rotation from their initial axis at end of surgery through all follow up visits at 1 hour, 1 week, 1 month and 6 months 11
  • Delivery by multiSert ™, providing unmatched control at your fingertips

Reference:

  • 1 Glistening-free  per  Miyata  scale;  study  result  of  the  David  J  Apple  International  Laboratory  for  Ocular  Pathology,  University  Hospital  Heidelberg.  Report  on  file.
  • 2 HOYA  data  on  file.  DoF-CTM-21-002,  HOYA  Medical Singapore Pte. Ltd, 2021.
  • 3 Pérez-Merino, P.; Marcos, S. (2018): Effect of intraocular lens decentration on image quality tested in a custom model eye. In: Journal of cataract and refractive surgery 44 (7), p. 889–896.
  • 4 Leydolt, C. et al. (2020): Posterior capsule opacification with two hydrophobic acrylic intraocular lenses: 3-year results of a randomized trial. In: American journal of ophthalmology 217 (9), p. 224-231.
  • 5 Giacinto, C. et al. (2019): Surface properties of commercially available hydrophobic acrylic intraocular lenses: Comparative study. In: Journal of cataract and refractive surgery 45 (9), p. 1330–1334.
  • 6 Werner, L. et al. (2019): Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. In: Journal of cataract and refractive surgery 45 (10), p. 1490–1497.
  • 7 Nanavaty, M. et al. (2019): Edge profile of commercially available square-edged intraocular lenses: Part 2. In: Journal of cataract and refractive surgery 45 (6), p. 847–853.
  • 8 Matsushima, H. et al. (2006): Active oxygen processing for acrylic intraocular lenses to prevent posterior capsule opacification. In: Journal of cataract and refractive surgery 32 (6), p. 1035–1040.
  • 9 Farukhi, A. et al. (2015): Evaluation of uveal and capsule biocompatibility of a single-piece hydrophobic acrylic intraocular lens with ultraviolet-ozone treatment on the posterior surface. In: Journal of cataract and refractive surgery 41 (5), p. 1081–1087.
  • 10 Eldred, J. et al. (2019): An In Vitro Human Lens Capsular Bag Model Adopting a Graded Culture Regime to Assess Putative Impact of IOLs on PCO Formation. In: Investigative ophthalmology & visual science 60 (1), p. 113–122.
  • 11 Schartmüller, D. et al. (2019): True rotational stability of a single-piece hydrophobic intraocular lens. In: The British journal of ophthalmology 103 (2), p. 186–190.
  • 12 HOYA data on file. DoF-SERT-102-MULT-03052018, HOYA Medical Singapore Pte. Ltd, 2018 13 At IOL plane. 14 Based on an average pseudophakic human eye.

Information contained is intended for health care professionals. For a full list of indications and contra indications please refer to the Instructions For Use. Some of the products and/or specific features as well as the procedures featured in this document may not be approved in your country and thus may not be available there. Design and specifications are subject to change without prior notice as a result of ongoing technical development. Please contact our regional representative regarding individual availability in your country. HOYA, Vivinex and multiSert are trademarks of the HOYA Corporation or its affiliates. ©2021 HOYA Medical Singapore Pte. Ltd. All rights reserved.

 
js_function_caller_helper